P. Paggiaro (Pisa, Italy), N. Thomson (Glasgow, United Kingdom), G. D'Amato (Naples, Italy)
Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma
H. Ohbayasshi, N. Shibata, M. Adachi (Mizunami, Tokyo, Japan)
|  |
Montelukast as add-on therapy may improve some indices of small airways involvement in uncontrolled asthmatics
L. Malagrinò, F. Costa, L. Melosini, A. Di Franco, G. Catapano, P. Paggiaro (Pisa, Italy)
| |
The eXpeRience registry: Monitoring the ‘real-world‘ effectiveness of omalizumab in allergic asthma
G. J. Braunstahl, J. Leo, C. W. Chen, R. Maykut, P. Georgiou, G. Peachey (Rotterdam, Netherlands; Horsham, United Kingdom; East Hanover, United States Of America; Basel, Switzerland)
|  |
Omalizumab and malignancy: Interim results from the EXCELS study
M. Eisner, M. Miller, W. Chou, A. Rahmaoui, M. Bradley (South San Francisco, United States Of America)
| |
Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review
B. Chauhan, F. Ducharme (Montreal, Canada)
| |
Real-life effectiveness of beclomethasone diproprionate/formoterol extra-fine combination in adult patients with persistent asthma
G. G. Brusselle, P. Van Den Brande, R. Peché, B. Fonteyn, D. Iacono, M. Blockmans, J. Bruhwyler, W. Hollanders (Ghent, Duffel, Montigny-le-Tilleul, Zutendaal, Malmedy, Court-Saint-Etienne, Ecaussinnes, Brussels, Belgium)
| |
Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma
N. Lazarinis, L. Bjermer, K. H. Carlsen, B. Dahlén, T. Ekström, G. Hedlin, L. Jörgensen, T. Pullerits, K. Larsson (Stockholm, Lund, Södertälje, Gothenburg, Sweden; Oslo, Norway)
| |
Randomized, placebo-controlled study of asthmatic smokers treated with montelukast or mid-dose fluticasone
D. Price, T. Popov, L. Bjermer, S. Lu, R. Petrovic, A. Mehta, J. Strus, P. Peter, G. Philip (Aberdeen, United Kingdom; Sofia, Bulgaria; Lund, Sweden; Whitehouse Station, United States Of America)
| |
‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study
A. Michils, O. Vandenplas, G. Brusselle, C. Lee, J. Van Schoor, S. Gurdain, C. Hermans, S. Vancayzeele, K. MacDonald, I. Abraham (Brussels, Yvoir, Ghent, Vilvoorde, Belgium; Earlysville, Oregon, Tucson, United States Of America)
| |
Plasma and urinary concentrations of inhaled salmeterol in healthy and persons with asthma – Quantifying a doping limit
M. Hostrup, J. Elers, J. Henninge, K. Dalhoff, V. Backer (Copenhagen, Denmark; Oslo, Norway)
| |
The effect of liposome inhalation on non-invasive oxidative stress markers in patients with bronchial asthma
A. Lisitsa, I. Klimanov, S. Soodaeva (Moscow, Russian Federation)
| |
Quantitative IgE levels in asthma and implications for treatment with omalizumab. Are the cutoffs to narrow?
M. L. Zaremba, K. Elliott, A. Redford, N. Shah, S. Ali, S. Reddy (Port Huron, United States Of America)
| |
The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients
S. Olgun Tandogdu, B. Bagci Ceyhan, A. Ikinci, R. Ahiskali (Istanbul, Turkey)
| |
Stability and achievement of asthma control with higher doses of inhaled conticosteroids regular treatment
S. L. Cheng (Taipei, Taiwan)
| |
Comparison of the efficacy of cicleosonide with budesonide in mild to moderate asthma patients after step-down therapy
K. C. Chiu, J. Y. Hsu, M. S. Lin, W. T. Liu, C. H. Wang, H. P. Kuo (Luodong Town, I-Lan County, Taichung, Chiayi, Taipei, Taiwan)
| |
The effect of GSK2190915, a 5-lipoxygenase activating protein inhibitor, on the early asthmatic response to inhaled allergen
V. Norris, J. Bentley, S. Kent, D. Singh, M. Boyce, B. Leaker (Stevenage, Manchester, London, United Kingdom)
| |
Asthma control and lung function after step down from high dose ICS/LABA combination therapy
P. Paggiaro, N. Gabriele, N. Crimi, L. M. Fabbri, D. Olivieri, A. Rossi, A. Papi (Pisa, Parma, Catania, Modena, Verona, Ferrara, Italy)
| |
Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroids
P. O‘Byrne, S. Rennard, F. Radner, S. Peterson, L. G. Carlsson, D. Sin (Hamilton, Vancouver, Canada; , United States Of America; Lund, Sweden)
| |
Increased incidence of pulmonary embolism in severe asthma
C. Majoor, P. Kamphuisen, L. Rijssenbeek-Nouwens, T. van der Poll, A. Zwinderman, P. Sterk, H. Büller, E. Bel (Amsterdam, Netherlands; Davos Wolfgang, Switzerland)
| |
Effects of hydrocortisone on acute beta-blocker and histamine induced bronchoconstriction
P. Short, P. Williamson, L. McKinlay, B. Lipworth (Dundee, United Kingdom)
| |